These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24142604)

  • 1. Evaluation of treatment with hydrocortisone on oxidant/antioxidant system in preterm infants with BPD.
    Sandal G; Mutlu B; Uras N; Erdeve O; Oguz SS; Dilmen U
    Eur Rev Med Pharmacol Sci; 2013 Oct; 17(19):2594-7. PubMed ID: 24142604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total antioxidant capacity and total oxidant status after surfactant treatment in preterm infants with respiratory distress syndrome.
    Dizdar EA; Uras N; Oguz S; Erdeve O; Sari FN; Aydemir C; Dilmen U
    Ann Clin Biochem; 2011 Sep; 48(Pt 5):462-7. PubMed ID: 21775575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total oxidant status and oxidative stress are increased in infants with necrotizing enterocolitis.
    Aydemir C; Dilli D; Uras N; Ulu HO; Oguz SS; Erdeve O; Dilmen U
    J Pediatr Surg; 2011 Nov; 46(11):2096-100. PubMed ID: 22075338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of phototherapy using different light sources on oxidant and antioxidant status of neonates with jaundice.
    Kale Y; Aydemir O; Celik Ü; Kavurt S; Isikoglu S; Bas AY; Demirel N
    Early Hum Dev; 2013 Dec; 89(12):957-60. PubMed ID: 24090867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of oxidant/antioxidant system in newborns and their breast milks.
    Sandal G; Uras N; Gokmen T; Oguz SS; Erdeve O; Dilmen U
    J Matern Fetal Neonatal Med; 2013 Mar; 26(5):540-3. PubMed ID: 23211119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of patent ductus arteriosus and subsequent therapy with ibuprofen on the release of S-100B and oxidative stress index in preterm infants.
    Demir N; Ece İ; Peker E; Kaba S; Ustyol L; Balahoroğlu R; Tuncer O
    Med Sci Monit; 2014 Dec; 20():2799-805. PubMed ID: 25542161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrocortisone treatment for bronchopulmonary dysplasia and brain volumes in preterm infants.
    Kersbergen KJ; de Vries LS; van Kooij BJ; Išgum I; Rademaker KJ; van Bel F; Hüppi PS; Dubois J; Groenendaal F; Benders MJ
    J Pediatr; 2013 Sep; 163(3):666-71.e1. PubMed ID: 23706359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
    Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Neonatology; 2010; 98(2):111-7. PubMed ID: 20150750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
    Yoder BA; Harrison M; Clark RH
    Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of urinary inflammatory and oxidative stress markers in very low birth weight infants with subsequent development of bronchopulmonary dysplasia.
    Joung KE; Kim HS; Lee J; Shim GH; Choi CW; Kim EK; Kim BI; Choi JH
    Free Radic Res; 2011 Sep; 45(9):1024-32. PubMed ID: 21651454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants.
    Hitzert MM; Benders MJ; Roescher AM; van Bel F; de Vries LS; Bos AF
    Pediatr Res; 2012 Jan; 71(1):100-6. PubMed ID: 22289857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm-born children.
    Rademaker KJ; Uiterwaal CS; Groenendaal F; Venema MM; van Bel F; Beek FJ; van Haastert IC; Grobbee DE; de Vries LS
    J Pediatr; 2007 Apr; 150(4):351-7. PubMed ID: 17382109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of two different lipid emulsions on morbidities and oxidant stress statuses in preterm infants: an observational study.
    Unal S; Demirel N; Erol S; Isik DU; Kulali F; Iyigun F; Bas AY
    J Matern Fetal Neonatal Med; 2018 Apr; 31(7):850-856. PubMed ID: 28298173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan.
    Onland W; Merkus MP; Nuytemans DH; Jansen-van der Weide MC; Holman R; van Kaam AH;
    Trials; 2018 Mar; 19(1):178. PubMed ID: 29523175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total antioxidant capacity and total oxidant status in perinatal asphyxia in relation to neurological outcome.
    Aydemir O; Akar M; Uras N; Eras Z; Erdeve O; Oguz SS; Dilmen U
    Neuropediatrics; 2011 Dec; 42(6):222-6. PubMed ID: 22144010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum prolidase activity and oxidative stress markers in pregnancies with intrauterine growth restricted infants.
    Toy H; Camuzcuoglu H; Arioz DT; Kurt S; Celik H; Aksoy N
    J Obstet Gynaecol Res; 2009 Dec; 35(6):1047-53. PubMed ID: 20144170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of serum and bronchoalveolar fluid lavage pro- and anti-inflammatory cytokine levels for predicting bronchopulmonary dysplasia in premature infants.
    Köksal N; Kayik B; Çetinkaya M; Özkan H; Budak F; Kiliç Ş; Canitez Y; Oral B
    Eur Cytokine Netw; 2012 Jun; 23(2):29-35. PubMed ID: 22591771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative Stress Levels and Dynamic Thiol-Disulfide Balance in Preterm Newborns with Bronchopulmonary Dysplasia.
    Demirtas MS; Kilicbay F; Erdal H; Tunc G
    Lab Med; 2023 Nov; 54(6):587-592. PubMed ID: 36896684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients.
    Aslan M; Sabuncu T; Kocyigit A; Celik H; Selek S
    Nutr Metab Cardiovasc Dis; 2007 Dec; 17(10):734-40. PubMed ID: 17321120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.